Aviva’s Ingevity NGVT Stock Holding History

Aviva’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-26,251	Closed	-$1.21M	–	781
2016 Q3	$1.21M	Buy	26,251 +874	+3%	+$36.9K	0.01%	730
2016 Q2	$864K	Buy	+25,377	New	+$792K	0.01%	710

Other funds holding NGVT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Aviva's NGVT Position: Q4 2016 in Review

Aviva sold out of Ingevity (NGVT) in Q4 2016, closing a stake of 26,251 shares — an estimated $1.21M sold.

Aviva first reported a position in NGVT in Q2 2016 and held it in 2 quarters. The position peaked at $1.21M in Q3 2016. 268 funds tracked by Wall St. Rank hold NGVT as of Q4 2016.

Aviva reported no remaining Ingevity position as of Q4 2016 after selling out during the quarter.
Aviva sold 26,251 Ingevity shares in Q4 2016, an estimated $1.21M.
Aviva first reported a position in Ingevity in Q2 2016 and held it in 2 quarters.
Aviva's Ingevity position peaked at $1.21M in Q3 2016.
268 funds tracked by Wall St. Rank held Ingevity as of Q4 2016.

Based on Aviva's 13F filing for Q4 2016, filed 13 Feb 2017.